Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 3 |
Search Results
6 results
Results by year
Page 1
Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes.
Am J Epidemiol. 2023 Feb 24;192(3):328-333. doi: 10.1093/aje/kwac203.
Am J Epidemiol. 2023.
PMID: 36446573
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil.
Ranzani OT, Hitchings MDT, de Melo RL, de França GVA, Fernandes CFR, Lind ML, Torres MSS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J.
Ranzani OT, et al.
Nat Commun. 2022 Oct 6;13(1):5536. doi: 10.1038/s41467-022-33169-0.
Nat Commun. 2022.
PMID: 36202800
Free PMC article.
Item in Clipboard
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Aikawa NE, Medeiros-Ribeiro AC, Pasoto SG, Yuki EFN, Saad CGS, Pedrosa T, Lara AN, Ceneviva C, Bonfa E, Kallas EG, Avelino-Silva VI.
Netto LC, et al.
Lancet HIV. 2022 May;9(5):e323-e331. doi: 10.1016/S2352-3018(22)00033-9. Epub 2022 Mar 23.
Lancet HIV. 2022.
PMID: 35338835
Free PMC article.
Item in Clipboard
Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster.
Lau CS, Thundyil J, Oh MLH, Phua SK, Liang YL, Li Y, Huo J, Huang Y, Zhang B, Xu S, Aw TC.
Lau CS, et al.
Antibodies (Basel). 2022 Nov 8;11(4):70. doi: 10.3390/antib11040070.
Antibodies (Basel). 2022.
PMID: 36412836
Free PMC article.
Item in Clipboard
Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai.
Yang D, Weng H, Wang R, Li Y, Zhang H, Shao S, Huang H, Song Y, Chen X, Hou D, Wu Y, Lu X, Yang W, Chen Z, Hu X, Xuan J, Bai C, Wang Y.
Yang D, et al.
Front Med (Lausanne). 2023 Feb 8;10:1079165. doi: 10.3389/fmed.2023.1079165. eCollection 2023.
Front Med (Lausanne). 2023.
PMID: 36844224
Free PMC article.
Item in Clipboard
The effectiveness of COVID-19 vaccination against all-cause mortality in patients with type 2 diabetes mellitus: The observation during the initial period of the cancellation of the "Dynamic Zero Policy" in mainland China.
Liu S, Jiang C, Liu Y, Zhang Y, Qiu X, Luo J, Xu Y, Wang J.
Liu S, et al.
Diabetes Res Clin Pract. 2023 Jun;200:110694. doi: 10.1016/j.diabres.2023.110694. Epub 2023 May 8.
Diabetes Res Clin Pract. 2023.
PMID: 37164159
Free PMC article.
Item in Clipboard
Cite
Cite